Starpharma (SPHRY) Short Interest Ratio & Short Volume $0.63 -0.04 (-5.97%) As of 03/11/2025 03:42 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartShort Interest Starpharma Short Interest DataStarpharma (SPHRY) has a short interest of 100 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a ∞ increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 1,294 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest0 sharesChange Vs. Previous Month+∞Dollar Volume Sold Short$75.11Short Interest Ratio0.3 Days to CoverLast Record DateFebruary 28, 2025Outstanding Shares41,811,000 sharesShort Percent of Float0.00%Today's Trading Volume3,300 sharesAverage Trading Volume1,294 sharesToday's Volume Vs. Average255% Short Selling Starpharma? Sign up to receive the latest short interest report for Starpharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSPHRY Short Interest Over TimeSPHRY Days to Cover Over TimeSPHRY Percentage of Float Shorted Over Time Remove Ads Starpharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/28/2025100 shares $75.11 No Change0.0%0.3 $0.75 1/15/20259,200 shares $6,424.82 +1,050.0%N/A46 $0.70 12/31/2024800 shares $514.64 -11.1%N/A0.1 $0.64 12/15/2024900 shares $672.77 -65.4%N/A1.3 $0.75 11/30/20242,600 shares $1,746.94 No ChangeN/A0.8 $0.67 11/15/20242,600 shares $1,916.20 -42.2%N/A0.2 $0.74 10/31/20244,500 shares $2,677.50 +66.7%N/A0.8 $0.60 10/15/20242,700 shares $1,597.32 No ChangeN/A3.9 $0.59 9/30/20242,700 shares $2,052.00 No ChangeN/A1 $0.76 9/15/20242,700 shares $1,755.00 No ChangeN/A13.5 $0.65 Get the Latest News and Ratings for SPHRY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Starpharma and its competitors with MarketBeat's FREE daily newsletter. 8/31/20242,700 shares $1,404.27 -25.0%N/A3.9 $0.52 8/15/20243,600 shares $2,066.40 No ChangeN/A36 $0.57 7/31/20243,600 shares $2,232.00 -20.0%N/A2.8 $0.62 7/15/20244,500 shares $2,700.00 -18.2%N/A11.3 $0.60 6/30/20245,500 shares $3,465.69 +96.4%N/A2.5 $0.63 6/15/20242,800 shares $1,958.04 No ChangeN/A7.1 $0.70 5/31/20242,800 shares $2,339.68 No ChangeN/A1.3 $0.84 5/15/20242,800 shares $2,023.00 +21.7%N/A4 $0.72 4/30/20242,300 shares $2,070.00 -14.8%N/A1 $0.90 4/15/20242,700 shares $2,322.00 No ChangeN/A1.5 $0.86 3/31/20242,700 shares $2,214.00 -70.0%N/A1.9 $0.82 3/15/20249,000 shares $7,830.00 +12.5%N/A0.7 $0.87 2/29/20248,000 shares $7,601.60 +9.6%N/A2.7 $0.95 2/15/20247,300 shares $6,935.00 -7.6%N/A3.7 $0.95 1/15/20248,200 shares $8,446.00 -4.7%N/A10.2 $1.03 12/31/20238,600 shares $10,698.40 +45.8%N/A2.4 $1.24 12/15/20235,900 shares $5,510.01 +78.8%N/A1.2 $0.93 11/30/20233,300 shares $3,234.00 -37.7%N/A0.9 $0.98 11/15/20235,300 shares $0.00 No ChangeN/A13.3 $0.00 10/31/20235,300 shares $4,858.51 +140.9%N/A4.1 $0.92 10/15/20232,200 shares $2,024.00 -50.0%N/A1.2 $0.92 9/30/20234,400 shares $4,774.00 +10.0%N/A2.3 $1.09 9/15/20234,000 shares $3,580.40 -16.7%N/A0.5 $0.90 8/31/20234,800 shares $4,656.00 +84.6%N/A0.9 $0.97 8/15/20232,600 shares $2,834.00 No ChangeN/A0.5 $1.09 6/15/2023200 shares $520.00 No ChangeN/A0.4 $2.60 5/31/2023200 shares $580.00 No ChangeN/A2 $2.90 5/15/2023200 shares $608.00 +100.0%N/A0.2 $3.04 4/30/2023100 shares $325.00 No ChangeN/A0.1 $3.25 4/15/2023100 shares $307.00 No ChangeN/A0.1 $3.07A deadly mistake in my prediction… (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 3/31/2023100 shares $318.00 No ChangeN/A0.1 $3.18 3/15/2023100 shares $306.00 No ChangeN/A0.1 $3.06 2/28/2023100 shares $350.00 No ChangeN/A0.3 $3.50 2/15/2023100 shares $387.00 -50.0%N/A0.5 $3.87 1/31/2023200 shares $924.00 -33.3%N/A0.4 $4.62 1/15/2023300 shares $1,381.68 No ChangeN/A0.1 $4.61 12/30/2022300 shares $1,092.00 No ChangeN/A0.1 $3.64 12/15/2022300 shares $1,035.00 -40.0%N/A0.2 $3.45 11/30/2022500 shares $1,775.00 -16.7%N/A0.6 $3.55 11/15/2022600 shares $2,310.00 No ChangeN/A0.5 $3.85 10/31/2022600 shares $2,082.00 -45.5%N/A0.5 $3.47 10/15/20221,100 shares $4,543.00 No ChangeN/A0.3 $4.13 9/15/2022100 shares $405.00 No ChangeN/A0 $4.05 5/15/2022500 shares $2,700.00 No ChangeN/A0.4 $5.40 11/30/2021700 shares $5,285.00 -46.2%N/A0.2 $7.55 11/15/20211,300 shares $10,010.00 -51.9%N/A0.4 $7.70 10/29/20212,700 shares $21,303.00 +8.0%N/A0.6 $7.89 10/15/20212,500 shares $22,125.00 +92.3%N/A2.3 $8.85 9/30/20211,300 shares $11,973.13 -31.6%N/A0.6 $9.21 9/15/20211,900 shares $18,259.00 -17.4%N/A0.4 $9.61 8/31/20212,300 shares $20,700.00 No ChangeN/A0.5 $9.00 7/30/2021300 shares $3,048.00 +200.0%N/A0 $10.16 7/15/2021100 shares $1,005.00 -94.4%N/A0 $10.05 6/30/20211,800 shares $20,160.00 +157.1%N/A0.5 $11.20 6/15/2021700 shares $8,998.50 +75.0%N/A0.6 $12.86 5/28/2021400 shares $5,104.00 -55.6%N/A0.4 $12.76 5/14/2021900 shares $11,610.00 No ChangeN/A0.5 $12.90 4/15/2021200 shares $3,000.00 -83.3%N/A0.1 $15.00 3/31/20211,200 shares $18,900.00 +33.3%N/A0.6 $15.75 3/15/2021900 shares $13,014.00 +800.0%N/A0.3 $14.46 2/26/2021100 shares $1,720.00 -91.7%N/A0 $17.20 2/12/20211,200 shares $18,660.00 +1,100.0%N/A0.2 $15.55 1/29/2021100 shares $1,157.00 -75.0%N/A0.1 $11.57 12/31/2020800 shares $9,840.00 No ChangeN/A0.1 $12.30 11/30/20201,300 shares $12,974.00 -18.8%N/A0.5 $9.98 11/15/20201,600 shares $15,200.00 No ChangeN/A0.6 $9.50 10/15/20203,300 shares $36,217.50 -23.3%N/A1 $10.98 9/30/20204,300 shares $46,440.00 +168.8%N/A1.2 $10.80 9/15/20201,600 shares $19,808.00 -36.0%N/A0.2 $12.38 8/31/20202,500 shares $27,525.00 +66.7%N/A0.5 $11.01 8/14/20201,500 shares $11,070.00 +275.0%N/A0.6 $7.38 7/31/2020400 shares $3,000.00 -77.8%N/A0.4 $7.50 7/15/20201,800 shares $14,085.00 -21.7%N/A0.8 $7.83 6/30/20202,300 shares $18,699.00 No ChangeN/A1 $8.13 6/15/20202,300 shares $16,100.00 -20.7%N/A2.6 $7.00 5/29/20202,900 shares $20,155.00 No ChangeN/A2.6 $6.95 5/15/20202,900 shares $17,980.00 +45.0%N/A0.9 $6.20 4/30/20202,000 shares $13,200.00 +233.3%N/A0.5 $6.60 4/15/2020600 shares $3,570.00 -50.0%N/A0.4 $5.95 3/31/20201,200 shares $6,000.00 +140.0%N/A0.4 $5.00A deadly mistake in my prediction… (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 3/13/2020500 shares $2,950.00 -28.6%N/A0.2 $5.90 SPHRY Short Interest - Frequently Asked Questions What is Starpharma's current short interest? Short interest is the volume of Starpharma shares that have been sold short but have not yet been closed out or covered. As of February 28th, investors have sold 100 shares of SPHRY short. 0.00% of Starpharma's shares are currently sold short. Learn More on Starpharma's current short interest. What is a good short interest percentage for Starpharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Starpharma's floating shares are currently sold short. Is Starpharma's short interest increasing or decreasing? Starpharma saw a increase in short interest during the month of February. As of February 28th, there was short interest totaling 100 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Starpharma's short interest compare to its competitors? 0.00% of Starpharma's shares are currently sold short. Here is how the short interest of companies compare to Starpharma: Inotiv, Inc. (6.51%), Auxly Cannabis Group Inc. (0.05%), Bioqual, Inc. (0.02%), Luna Innovations Incorporated (5.35%), OneMedNet Co. (0.45%), bioAffinity Technologies, Inc. (1.23%), FOXO Technologies Inc. (6.68%), iSpecimen Inc. (14.47%), IQVIA Holdings Inc. (2.01%), ICON Public Limited (2.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks. What does it mean to sell short Starpharma stock? Short selling SPHRY is an investing strategy that aims to generate trading profit from Starpharma as its price is falling. SPHRY shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Starpharma? A short squeeze for Starpharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SPHRY, which in turn drives the price of the stock up even further. How often is Starpharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPHRY, twice per month. The most recent reporting period available is February, 28 2025. More Short Interest Resources from MarketBeat Related Companies NOTV Short Interest CBWTF Short Interest BIOQ Short Interest LUNA Short Interest ONMD Short Interest BIAF Short Interest FOXO Short Interest ISPC Short Interest IQV Short Interest ICLR Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:SPHRY) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredFormer CIA to Trump – Will you Shut down this secret lab?Deep in the sands of New Mexico lies a government lab so secret it makes Area 51 look like a tourist spot… ...Paradigm Press | SponsoredDeFi Coin on Verge of Breakout!We’re Opening the Ultimate Crypto Vault… Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Starpharma Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Starpharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SPHRY Stock Alerts